Is Atopic Dermatitis making you itch?

Are you suffering from itch?


The Study

  • A Phase 3, 4-week study reviewing the safety of a topical cream given QD in mild atopic dermatitis subjects

Study Benefits*

  • Study the safety and efficacy of an investigational topical cream for mild to moderate atopic dermatitis
  • Being studied in both children and adults
  • The study drug is a PD4-inhibitor
  • PD4 has been associated with higher production of pro-inflammatory mediators and lower production of the anti-inflammatory mediator IL-10
  • Therefore, the study drug works to directly block the PD4 and block inflammation of the skin
  • Non-steroidal topical cream with once daily dosing
  • All study related care and medication provided
  • Open label extension study available

Study Volunteers Must Meet the Following Criteria

  • 6 years and older with a diagnosis of mild to moderate atopic dermatitis
  • Not pregnant or breastfeeding or planning to do so

Study Participant Expectations

  • 2-month study duration with 5 study visits
  • Blood samples collected 3 times during course of study
  • Optional medical photography portion of the study available
  • Optional open label study available that allows participants to continue to receive the study treatment


  • There is no cost to participate
  • Patients who qualify may be compensated for time and travel

Register for a Study